))
Digital Politics with Karen Jagoda is a non-partisan podcast featuring thought leaders and industry pioneers with insights about innovative approaches to political campaigns, voter engagement, mobilization, fundraising, persuasion, and GOTV. Topics include the power of mobile devices, leveraging social networks, message testing and targeting, cross-media advertising, grassroots organizing, and big data.
…
continue reading
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
1
Power of the Influencer in Election 2024 with Ryan Davis PeopleFirst
23:32
23:32
Play later
Play later
Lists
Like
Liked
23:32
Ryan Davis, the Co-Founder and COO of PeopleFirst, shares insights and analysis about the activities of influencers and content creators in the campaign leading up to the 2024 election. While celebrity influencers have large followings, the voices of local people sharing authentic content about all kinds of interests broke through the noise to reac…
…
continue reading
1
Streamlining Dental Care Payments Improving Revenue Cycle Management with James Grover Vyne Dental TRANSCRIPT
James Grover, President of Vyne Dental, addresses the friction and inefficiencies in the dental healthcare system to facilitate payments and improve patient outcomes. The dental care environment is fragmented and lacks coordination between patients, dentists, and payers. Vyne Dental works with dental practices to streamline the revenue cycle manage…
…
continue reading
1
Streamlining Dental Care Payments Improving Revenue Cycle Management with James Grover Vyne Dental
18:10
18:10
Play later
Play later
Lists
Like
Liked
18:10
James Grover, President of Vyne Dental, addresses the friction and inefficiencies in the dental healthcare system to facilitate payments and improve patient outcomes. The dental care environment is fragmented and lacks coordination between patients, dentists, and payers. Vyne Dental works with dental practices to streamline the revenue cycle manage…
…
continue reading
1
Personalized T-Regulatory Cell Therapy for Type-1 Diabetes and Other Autoimmune Diseases with Professor Piotr Trzonkowski PolTREG TRANSCRIPT
Professor Piotr Trzonkowski, CEO of PolTREG, is focused on developing cell therapies for autoimmune diseases like type-1 diabetes and multiple sclerosis using polyclonal T-regulatory cell therapy. Treg cells are key in regulating the immune system and preventing autoimmune diseases. Clinical trials are showing promise for safe and effective treatme…
…
continue reading
1
Personalized T-Regulatory Cell Therapy for Type-1 Diabetes and Other Autoimmune Diseases with Professor Piotr Trzonkowski PolTREG
20:19
20:19
Play later
Play later
Lists
Like
Liked
20:19
Professor Piotr Trzonkowski, CEO of PolTREG, is focused on developing cell therapies for autoimmune diseases like type-1 diabetes and multiple sclerosis using polyclonal T-regulatory cell therapy. Treg cells are key in regulating the immune system and preventing autoimmune diseases. Clinical trials are showing promise for safe and effective treatme…
…
continue reading
1
Strategies to Strengthen Healthcare Cybersecurity and Mitigate the Impact of Cyber-Attacks with Cecil Pineda R1 RCM TRANSCRIPT
Cecil Pineda, Senior VP and Chief Information Security Officer at R1 RCM, is focused on integrating robust cybersecurity into the revenue cycle management process. When healthcare organizations are hit with ransomware attacks, they must respond rapidly and accurately communicate with internal and external partners. Long-term strategies include cont…
…
continue reading
1
Strategies to Strengthen Healthcare Cybersecurity and Mitigate the Impact of Cyber-Attacks with Cecil Pineda R1 RCM
19:58
19:58
Play later
Play later
Lists
Like
Liked
19:58
Cecil Pineda, Senior VP and Chief Information Security Officer at R1 RCM, is focused on integrating robust cybersecurity into the revenue cycle management process. When healthcare organizations are hit with ransomware attacks, they must respond rapidly and accurately communicate with internal and external partners. Long-term strategies include cont…
…
continue reading
1
Seeking Brain Donations to Advance Research and Understanding of Autism with Dorothy Frisch and Dr. David Amaral Autism BrainNet TRANSCRIPT
David explains, "We went to the Simons Foundation and, with their support, have established a network in the United States. We have three collection sites: one at the UC Davis Mind Institute in Sacramento, one at UT Southwestern in Dallas, Texas, and one at the Mass General Hospital in Boston, where a postmortem brain donation can be sent. Those br…
…
continue reading
1
Seeking Brain Donations to Advance Research and Understanding of Autism with Dorothy Frisch and Dr. David Amaral Autism BrainNet
28:14
28:14
Play later
Play later
Lists
Like
Liked
28:14
This is a conversation with Dr. David Amaral, a distinguished professor at the MIND Institute and scientific director of Autism BrainNet, and Dorothy Frisch, an activist and supporter of the program. Autism BrainNet is funded by the Simons Foundation to collect and study postmortem brain samples from individuals with autism to understand the neurol…
…
continue reading
1
Raising Thiamine Levels in the Brain to Treat Early Alzheimer’s Disease Dr. Jose Luchsinger Benfo Team TRANSCRIPT
Dr. Jose Luchsinger, Vice Chair for Clinical and Epidemiologic Research at Columbia University, is leading a phase 2 clinical trial of a prodrug Benfo that aims to raise the level of thiamine in the brain to improve memory and function in people with early Alzheimer's disease. This effort is based on research showing that Alzheimer's is associated …
…
continue reading
1
Raising Thiamine Levels in the Brain to Treat Early Alzheimer’s Disease Dr. Jose Luchsinger Benfo Team
25:07
25:07
Play later
Play later
Lists
Like
Liked
25:07
Dr. Jose Luchsinger, Vice Chair for Clinical and Epidemiologic Research at Columbia University, is leading a phase 2 clinical trial of a prodrug Benfo that aims to raise the level of thiamine in the brain to improve memory and function in people with early Alzheimer's disease. This effort is based on research showing that Alzheimer's is associated …
…
continue reading
1
AI-Powered Tools Save Physicians Time and Enhance Doctor-Patient Conversations with Dr. Michael Sherling ModMed TRANSCRIPT
Dr. Michael Sherling, Co-Founder, Chief Medical Officer, and Strategy Officer at ModMed, aims to save time for physicians and patients by reducing administrative burden through technology. Their AI-based solutions focus on automating mundane tasks like fax routing and documentation and can passively transcribe doctor-patient conversations to genera…
…
continue reading
1
AI-Powered Tools Save Physicians Time and Enhance Doctor-Patient Conversations with Dr. Michael Sherling ModMed
20:37
20:37
Play later
Play later
Lists
Like
Liked
20:37
Dr. Michael Sherling, Co-Founder, Chief Medical Officer, and Strategy Officer at ModMed, aims to save time for physicians and patients by reducing administrative burden through technology. Their AI-based solutions focus on automating mundane tasks like fax routing and documentation and can passively transcribe doctor-patient conversations to genera…
…
continue reading
1
Antibody Drug Targets Toxic Amyloid Oligomers from Alzheimer’s Disease with Dr. Eric Siemers Acumen Pharma TRANSCRIPT
Dr. Eric Siemers, Medical Officer at Acumen Pharma, is developing a monoclonal antibody called sabirnetug that targets a specific toxic form of amyloid beta, Aβ oligomers. These oligomers are now believed to be a key driver of neuronal damage in Alzheimer's disease. The drug is in phase 2 clinical trials to evaluate its ability to slow cognitive de…
…
continue reading
1
Antibody Drug Targets Toxic Amyloid Oligomers from Alzheimer’s Disease with Dr. Eric Siemers Acumen Pharma
22:31
22:31
Play later
Play later
Lists
Like
Liked
22:31
Dr. Eric Siemers, Medical Officer at Acumen Pharma, is developing a monoclonal antibody called sabirnetug that targets a specific toxic form of amyloid beta, Aβ oligomers. These oligomers are now believed to be a key driver of neuronal damage in Alzheimer's disease. The drug is in phase 2 clinical trials to evaluate its ability to slow cognitive de…
…
continue reading
1
Integrating the Patient Perspective in Defining and Promoting Value-Based Healthcare with Rob Abbott ISPOR TRANSCRIPT
Rob Abbott, CEO and Executive Director at ISPOR, the Professional Society for Health Economics and Outcomes Research, focuses on defining and measuring value in healthcare, including accessibility, affordability, effectiveness, and patient outcomes. HEOR (health economics and outcomes research) can provide data-driven insights to guide healthcare d…
…
continue reading
1
Integrating the Patient Perspective in Defining and Promoting Value-Based Healthcare with Rob Abbott ISPOR
17:21
17:21
Play later
Play later
Lists
Like
Liked
17:21
Rob Abbott, CEO and Executive Director at ISPOR, the Professional Society for Health Economics and Outcomes Research, focuses on defining and measuring value in healthcare, including accessibility, affordability, effectiveness, and patient outcomes. HEOR (health economics and outcomes research) can provide data-driven insights to guide healthcare d…
…
continue reading
1
Identification of Genetic Biomarker Leads to Effective Drug to Treat Alcohol Use Disorder with Tony Goodman Adial Pharmaceuticals TRANSCRIPT
Tony Goodman is the Chief Operating Officer at Adial Pharmaceuticals, which is developing a personalized therapy for alcohol use disorder based on a genetic biomarker. This unique approach combines the therapeutic AD04 with the biomarker AG Plus to identify a specific AUD patient population that responds well to this drug. Insights from this work c…
…
continue reading
1
Identification of Genetic Biomarker Leads to Effective Drug to Treat Alcohol Use Disorder with Tony Goodman Adial Pharmaceuticals
22:47
22:47
Play later
Play later
Lists
Like
Liked
22:47
Tony Goodman is the Chief Operating Officer at Adial Pharmaceuticals, which is developing a personalized therapy for alcohol use disorder based on a genetic biomarker. This unique approach combines the therapeutic AD04 with the biomarker AG Plus to identify a specific AUD patient population that responds well to this drug. Insights from this work c…
…
continue reading
1
Computational AI Bringing Predictability Precision to Drug Discovery and Clinical Trials with Shai Shen-Orr CytoReason TRANSCRIPT
Shai Shen-Orr, the Co-Founder and Chief Scientist of CytoReason, is developing computational disease models powered by AI to improve the probability of success in phase 2 clinical trials. Their goal is to more precisely develop drugs using AI to analyze large amounts of biological and clinical data and overcome the challenges of the complexity and …
…
continue reading
1
Computational AI Bringing Predictability Precision to Drug Discovery and Clinical Trials with Shai Shen-Orr CytoReason
21:13
21:13
Play later
Play later
Lists
Like
Liked
21:13
Shai Shen-Orr, the Co-Founder and Chief Scientist of CytoReason, is developing computational disease models powered by AI to improve the probability of success in phase 2 clinical trials. Their goal is to more precisely develop drugs using AI to analyze large amounts of biological and clinical data and overcome the challenges of the complexity and …
…
continue reading
1
Food as Medicine Platform Offers Personalized Nutrition Therapy with Josh Hix Season Health TRANSCRIPT
Josh Hix, the CEO of Season Health, has developed a food as medicine platform that combines registered dietitian services, food delivery, and medical nutrition therapy. This makes it easier for patients to access food benefits and eat healthier. The rise of GLP-1 agonist medications for weight management has highlighted the need to develop personal…
…
continue reading
1
Food as Medicine Platform Offers Personalized Nutrition Therapy with Josh Hix Season Health
19:27
19:27
Play later
Play later
Lists
Like
Liked
19:27
Josh Hix, the CEO of Season Health, has developed a food as medicine platform that combines registered dietitian services, food delivery, and medical nutrition therapy. This makes it easier for patients to access food benefits and eat healthier. The rise of GLP-1 agonist medications for weight management has highlighted the need to develop personal…
…
continue reading
1
Mid-Size CRO Offers Flexibility Collaboration and AI Tools to Transform Clinical Trials with Dr. Philip Räth Palleos Healthcare TRANSCRIPT
Dr. Philip Räth, Managing Director at Palleos, discusses the advantages of a mid-size contract research organization compared to a large CRO. Customized solutions, strong cross-departmental cooperation, and fast decision-making are key to addressing the most significant unmet needs of clinical trial sponsors. This nimble clinical trial model, suppo…
…
continue reading
1
Mid-Size CRO Offers Flexibility Collaboration and AI Tools to Transform Clinical Trials with Dr. Philip Räth Palleos Healthcare
20:30
20:30
Play later
Play later
Lists
Like
Liked
20:30
Dr. Philip Räth, Managing Director at Palleos, discusses the advantages of a mid-size contract research organization compared to a large CRO. Customized solutions, strong cross-departmental cooperation, and fast decision-making are key to addressing the most significant unmet needs of clinical trial sponsors. This nimble clinical trial model, suppo…
…
continue reading
